Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells

Journal of Molecular Neuroscience

Volumn 36, Issue 1-3, 2008, Pages 286-291

  Sokolowska, Paulina ^a   Nowak, Jerzy Z ^a,b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

cAMP; PACAP; Proliferation; Rat glioma cells; VIP

Indexed keywords

CYCLIC AMP; DUAL SPECIFICITY PHOSPHATASE 2; FORSKOLIN; HELODERMIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BUCLADESINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP; ENZYME INHIBITORS; FORSKOLIN; PEPTIDE FRAGMENTS; PEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; SECRETIN; VASOACTIVE INTESTINAL PEPTIDE;

RATTUS;

EID: 58149093668     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9071-9     Document Type: Article

References (37)

1. A. Arimura 1998 Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems Japanese Journal of Physiology 48 301 331
2. W. Bik E. Wolinska-Witort J. Pawlak K. Skwarlo-Sonta 2006 PACAP38 as a modulator of immune and endocrine responses during LPS-induced acute inflammation in rats Journal of Neuroimmunology 177 76 84
3. T. Dalsgaard J. Hannibal J. Fahrenkrug C. R. Larsen 2003 VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries Regulatory Peptides 110 179 188
4. A. Dejda M. Jozwiak-Bebenista J. Z. Nowak 2006 PACAP, VIP, and PHI: Effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures Annals of the New York Academy of Sciences 1070 220 225
5. C. Dufes C. Alleaume A. Montoni J.-C. Olivier 2003 Effects of the vasoactive intestinal peptide (VIP) and relate peptides on glioblastoma cell growth in vitro Journal of Molecular Neuroscience 21 97 108
6. L. L. Dugan J. S. Kim Y. Zhang R. D. Bart 1999 Differential effects of cAMP in neurons and astrocytes. Role of b-Raf Journal of Biological Chemistry 274 25842 25848
7. M. Fabry C. Cabrele H. Hocker A. G. Beck-Sickinger 2000 Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line Peptides 21 1885 1893
8. D. Farini A. Puglianiello C. Mammi G. Siracusa 2003 Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: Short- and long-term exposure affect proliferation and neuroendocrine differentiation Endocrinology 144 1631 1643
9. H. Ghzili L. Grumolato H. Vaudry Y. Anouar 2006 Possible implication of the transcriptional regulator Id3 in PACAP-induced pro-survival signaling during PC12 cell differentiation Regulatory Peptides 137 89 94
10. S. Goursaud N. Pineau L. Becq-Giraudon P. Gressens 2005 Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: Implication of a GTP-sensitive form of VPAC1 receptor Journal of Neuroimmunology 158 94 105
11. I. Gozes M. Fridkin J. M. Hill D. E. Brenneman 1999 Pharmaceutical VIP: Prospects and problems Current Medicinal Chemistry 6 1019 1034
12. A. J. Harmar A. Arimura I. Gozes L. Journot 1998 International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide Pharmacological Reviews 50 265 270
13. C. Heraud S. Hilairet J. M. Muller J. F. Leterrier 2004 Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins Journal of Neuroscience Research 75 320 329
14. D. M. Jaworski 2000 Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and response to acute intracranial injury Cell and Tissue Research 300 219 230
15. M. Kurino K. Fukunaga Y. Ushio E. Miyamoto 1996 Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes Journal of Neurochemistry 67 2246 2255
16. M. Laburthe A. Couvineau V. Tan 2007 Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology Peptides 28 1631 1639
17. S. V. Le D. J. Yamaguchi C. A. McArdle K. Tachiki 2002 PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells Regulatory Peptides 109 115 125
18. V. Lelievre A. C. Meunier E. Caigneaux J. Falcon 1998 Differential expression and function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines Cellular Signaling 10 13 26
19. V. Lelievre N. Pineau J. Du C. H. Wen 1998 Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation Journal of Biological Chemistry 273 19685 19690
20. J. Leyton T. Coelho D. H. Coy S. Jakolew 1998 PACAP(6-38) inhibits the growth of prostate cancer cells Cancer Letters 125 131 139
21. J. Leyton Y. Gozes J. Pisegna D. Coy 1999 PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells Breast Cancer Research and Treatment 56 177 186
22. N. Lu R. Zhou E. DiCicco-Bloom 1998 Opposing mitogenic regulation by PACAP in sympathetic and cerebral cortical precursors correlates with differential expression of PACAP receptor (PAC1-R) isoforms Journal of Neuroscience Research 53 651 662
23. T. K. Monaghan C. J. Mackenzie R. Plevin E. M. Lutz 2008 PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinase Journal of Neurochemistry 104 74 88
24. T. W. Moody J. M. Hill R. T. Jensen 2003 VIP as a trophic factor in the CNS and cancer cells Peptides 24 163 177
25. A. Nicot E. DiCicco-Bloom 2001 Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression Proceedings of the National Academy of Sciences 98 4758 4763
26. J. Z. Nowak J. B. Zawilska 2003 PACAP in avians: Origin, occurrence, and receptors-Pharmacological and functional considerations Current Pharmaceutical Design 9 465 481
27. G. G. Nussdorfer L. K. Malendowicz 1998 Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis Peptides 19 1443 1467
28. J. C. Reubi U. Laderach B. Waser J. O. Gebbers 2000 Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin Cancer Research 60 3105 3112
29. Y. Salomon C. Londos M. Rodbell 1974 A highly sensitive adenylate cyclase assay Analytical Biochemistry 58 541 544
30. S. Schulz C. Rocken C. Mawrin W. Weise 2004 Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastc human tissues with subtype-specific antibodies Clinical Cancer Research 10 8235 8242
31. A. Sharma J. Walters Y. Gozes M. Fridkin 2001 A vasoactive intestinal peptide antagonist inhibits growth of glioblastoma cells Journal of Molecular Neuroscience 17 331 339
32. H. Shimizu J. W. Daly C. R. Creveling 1969 A radioisotopic method for measuring the formation of adenosine 3¢, 5¢-cyclic monophosphate in incubated slices of brain Journal of Neurochemistry 16 1609 1619
33. P. Sokolowska J. Z. Nowk 2006 Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages Annals of the New York Academy of Sciences 1070 566 569
34. I. Vallejo M. Vallejo 2002 Pituitary adenylate cyclase-activating polypeptide induces astrocyte differentiation of precursor cells from developing cerebral cortex Molecular and Cellular Neuroscience 21 671 683
35. D. Vaudry B. J. Gonzalez M. Basille L. Yon 2000 Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions Pharmacological Reviews 52 269 324
36. P. Vertongen I. Camby F. Darro R. Kiss 1996 VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor Neuropeptides 30 491 496
37. J. A. Waschek 2002 Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration Developmental Neuroscience 24 14 23